TP53 mutations determined by targeted NGS in breast cancer: a case-control study

Αngeliki Andrikopoulou; Evangelos Terpos; Spyridoula Chatzinikolaou; Kleoniki Apostolidou; Ioannis Ntanasis‐Stathopoulos; Maria Gavriatopoulou; Meletios A Dimopoulos; Flora Zagouri

doi:10.18632/oncotarget.28071

Article2022

Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer

Eleni Zografos, Αngeliki Andrikopoulou, Alkistis Papatheodoridi, Maria Kaparelou, Garyfalia Bletsa, Michalis Liontos, Meletios A Dimopoulos, Flora Zagouri

Preprint2023

Data from TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Emmanuelle Gormally, Paolo Vineis, Giuseppe Matullo, Fabrizio Veglia, Élodie Caboux, Emilie Le Roux, Marco Peluso, Seymour Garte, Simonetta Guarrera, Armelle Munnia, Luisa Airoldi, Herman Autrup, C. Malaveille, Alison M. Dunning, Kim Overvad, Anne Tjønneland, Eiliv Lund, Françoise Clavel-Chapelon, Heiner Boeing, Antonia Trichopoulou, Domenico Palli, Vittorio Krogh, Rosario Tumino, Salvatore Panico, H. Bas Bueno-de-Mesquita, Petra H. Peeters, Guillem Pera, Carmen Martı́nez, Miren Dorronsoro, Aurelio Barricarte, Carmen Navarro, J. Ramón Quirós, Göran Hallmans, ,

Preprint2023

Data from TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Emmanuelle Gormally, Paolo Vineis, Giuseppe Matullo, Fabrizio Veglia, Élodie Caboux, Emilie Le Roux, Marco Peluso, Seymour Garte, Simonetta Guarrera, Armelle Munnia, Luisa Airoldi, Herman Autrup, C. Malaveille, Alison M. Dunning, Kim Overvad, Anne Tjønneland, Eiliv Lund, Françoise Clavel-Chapelon, Heiner Boeing, Antonia Trichopoulou, Domenico Palli, Vittorio Krogh, ,

Article2017

Performance study of an amplification-based NGS test on clinical FFPE specimens in China’s first multi-center study.

Ye Feng, Xiaoyan Zhou, Huaiyin Shi, Haijing Liu, Li Liang, Xiaodong Teng, Zhe Wang, Sanpeng Xu, Guoping Wang, Gang Chen, Yingyong Hou, Huanwen M. Wu, Tingdong Tang, Rui Liu, Bo Zhang, Zhiyong Liang, Hong Bu

Journal of Clinical Oncology

Preprint2021

Colorectal cancer is associated with the presence of cancer driver mutations in normal colon

Julia Matas, Brendan F. Kohrn, Jeanne Fredrickson, Kelly Carter, Ming Yu, Ting Wang, Xianyong Gui, Thierry Soussi, Vı́ctor Moreno, William M. Grady, aaa bbb, Rosa Ana Risques

TP53 mutations determined by targeted NGS in breast cancer: a case-control study

Abstract

Discussion(0)

Related publications

Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer

Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Performance study of an amplification-based NGS test on clinical FFPE specimens in China’s first multi-center study.

Colorectal cancer is associated with the presence of cancer driver mutations in normal colon

TP53 mutations determined by targeted NGS in breast cancer: a case-control study

Abstract

Discussion(0)

Related publications

Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer

Data from &lt;i&gt;TP53&lt;/i&gt; and &lt;i&gt;KRAS2&lt;/i&gt; Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Data from &lt;i&gt;TP53&lt;/i&gt; and &lt;i&gt;KRAS2&lt;/i&gt; Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Performance study of an amplification-based NGS test on clinical FFPE specimens in China’s first multi-center study.

Colorectal cancer is associated with the presence of cancer driver mutations in normal colon

Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study